SRTS Stock Overview
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sensus Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.39 |
| 52 Week High | US$5.38 |
| 52 Week Low | US$1.79 |
| Beta | 0.94 |
| 1 Month Change | -10.08% |
| 3 Month Change | -3.69% |
| 1 Year Change | -27.10% |
| 3 Year Change | -15.04% |
| 5 Year Change | -47.28% |
| Change since IPO | -42.05% |
Recent News & Updates
Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16
Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11Recent updates
Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17We Discuss Why Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation May Be Closely Reviewed
May 30Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price
Apr 26Analysts Expect Breakeven For Sensus Healthcare, Inc. (NASDAQ:SRTS) Before Long
Apr 19Sensus Healthcare's (NASDAQ:SRTS) Stock Price Has Reduced 30% In The Past Three Years
Feb 23Holy Name Medical Center acquires Sensus low-dose radiation therapy system
Jan 06Shareholder Returns
| SRTS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.9% | -2.9% | -3.2% |
| 1Y | -27.1% | -3.7% | 19.3% |
Return vs Industry: SRTS underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: SRTS underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| SRTS volatility | |
|---|---|
| SRTS Average Weekly Movement | 11.6% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SRTS's share price has been volatile over the past 3 months.
Volatility Over Time: SRTS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 35 | Joe Sardano | sensushealthcare.com |
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Sensus Healthcare, Inc. Fundamentals Summary
| SRTS fundamental statistics | |
|---|---|
| Market cap | US$55.58m |
| Earnings (TTM) | US$485.00k |
| Revenue (TTM) | US$24.41m |
114.6x
P/E Ratio2.3x
P/S RatioIs SRTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SRTS income statement (TTM) | |
|---|---|
| Revenue | US$24.41m |
| Cost of Revenue | US$10.35m |
| Gross Profit | US$14.06m |
| Other Expenses | US$13.58m |
| Earnings | US$485.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 0.03 |
| Gross Margin | 57.61% |
| Net Profit Margin | 1.99% |
| Debt/Equity Ratio | 0% |
How did SRTS perform over the long term?
See historical performance and comparison